DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Sindet-Pedersen C, Pallisgaard JL, Staerk L. , et al.
Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - a Danish nationwide cohort study.
Sci Rep 2017;
7 (01) 3347
We do not assume any responsibility for the contents of the web pages of other providers.